Physician profile
William C Kramer
NPI 1093978223
$3,788.71
in general payments reported to CMS, 2019-2025
12 companies · $477 in 2025
The $477 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,712 · 2020: $218 · 2021: $44.07 · 2022: $16.88 · 2023: $93.01 · 2024: $228 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Education: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.61 |
| Education | $220.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Mountain Medical, LLC | $1,398.20 | 2019-2024 | |
| Wright Medical Technology, INC. | $718.38 | 2019 | |
| Stryker Corporation | $523.12 | 2021-2025 | Infinity Adaptis, Variax, Gamma |
| Smith+Nephew, INC. | $362.20 | 2019 | |
| Depuy Synthes Sales INC. | $354.62 | 2019-2025 | Va-Lcp, Fibergraft Bg Morsels, Motoband |
| Musculoskeletal Transplant Foundation INC. | $234.87 | 2020-2022 | |
| Davol INC. | $51.22 | 2024 | |
| Arthrosurface Incorporated | $43.04 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.06 | 2019-2023 | Euflexxa |
| Bioventus LLC | $23.94 | 2025 | Gelsyn-3 |
| Heron Therapeutics, INC. | $21.64 | 2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $19.42 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.